Your browser doesn't support javascript.
loading
PRKAR2B plays an oncogenic role in the castration-resistant prostate cancer.
Sha, Jianjun; Xue, Wei; Dong, Baijun; Pan, Jiahua; Wu, Xiaorong; Li, Dong; Liu, Dongming; Huang, Yiran.
Affiliation
  • Sha J; Department of Urology, Ren Ji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China.
  • Xue W; School of Biomedical Engineering, Shanghai Jiaotong University, Shanghai, People's Republic of China.
  • Dong B; Department of Urology, Ren Ji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China.
  • Pan J; Department of Urology, Ren Ji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China.
  • Wu X; Department of Urology, Ren Ji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China.
  • Li D; Department of Urology, Ren Ji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China.
  • Liu D; Department of Urology, Ren Ji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China.
  • Huang Y; Department of Urology, Ren Ji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China.
Oncotarget ; 8(4): 6114-6129, 2017 Jan 24.
Article in En | MEDLINE | ID: mdl-28008150

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cell Cycle Proteins / Gene Expression Profiling / Cyclic AMP-Dependent Protein Kinase RIIbeta Subunit / Prostatic Neoplasms, Castration-Resistant Limits: Animals / Humans / Male Language: En Journal: Oncotarget Year: 2017 Type: Article Affiliation country: China

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cell Cycle Proteins / Gene Expression Profiling / Cyclic AMP-Dependent Protein Kinase RIIbeta Subunit / Prostatic Neoplasms, Castration-Resistant Limits: Animals / Humans / Male Language: En Journal: Oncotarget Year: 2017 Type: Article Affiliation country: China